Keros Therapeutics, Inc. · NASDAQ:KROS
Alkeon Capital Management LLC's stake in Keros Therapeutics, Inc. fell to 2.70% (Schedule 13G)
Event Dec 31, 2024 · Filed Feb 14, 2025
Alkeon Capital Management LLC's stake in Keros Therapeutics, Inc. fell to 2.70%, 1,101,000 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G).
- Stake
- 2.70%
- Shares
- 1,101,000
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Alkeon Capital Management LLC | 2.70% | 1,101,000 |
| Panayotis D. Sparaggis | 2.70% | 1,101,000 |